Anti-NOE1/ OLFM1/ AMY functional antibody

Anti-NOE1/ OLFM1/ AMY functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OLFM1/OLFM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0385-Ab-1/ GM-Tg-hg-SE0385-Ab-2Anti-Human OLFM1 monoclonal antibodyHuman
GM-Tg-rg-SE0385-Ab-1/ GM-Tg-rg-SE0385-Ab-2Anti-Rat OLFM1 monoclonal antibodyRat
GM-Tg-mg-SE0385-Ab-1/ GM-Tg-mg-SE0385-Ab-2Anti-Mouse OLFM1 monoclonal antibodyMouse
GM-Tg-cynog-SE0385-Ab-1/ GM-Tg-cynog-SE0385-Ab-2Anti-Cynomolgus/ Rhesus macaque OLFM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0385-Ab-1/ GM-Tg-felg-SE0385-Ab-2Anti-Feline OLFM1 monoclonal antibodyFeline
GM-Tg-cang-SE0385-Ab-1/ GM-Tg-cang-SE0385-Ab-2Anti-Canine OLFM1 monoclonal antibodyCanine
GM-Tg-bovg-SE0385-Ab-1/ GM-Tg-bovg-SE0385-Ab-2Anti-Bovine OLFM1 monoclonal antibodyBovine
GM-Tg-equg-SE0385-Ab-1/ GM-Tg-equg-SE0385-Ab-2Anti-Equine OLFM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0385-Ab-1/ GM-Tg-hg-SE0385-Ab-2; GM-Tg-rg-SE0385-Ab-1/ GM-Tg-rg-SE0385-Ab-2;
GM-Tg-mg-SE0385-Ab-1/ GM-Tg-mg-SE0385-Ab-2; GM-Tg-cynog-SE0385-Ab-1/ GM-Tg-cynog-SE0385-Ab-2;
GM-Tg-felg-SE0385-Ab-1/ GM-Tg-felg-SE0385-Ab-2; GM-Tg-cang-SE0385-Ab-1/ GM-Tg-cang-SE0385-Ab-2;
GM-Tg-bovg-SE0385-Ab-1/ GM-Tg-bovg-SE0385-Ab-2; GM-Tg-equg-SE0385-Ab-1/ GM-Tg-equg-SE0385-Ab-2
Products NameAnti-OLFM1 monoclonal antibody
Formatmab
Target NameOLFM1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OLFM1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0385-Ag-1Recombinant multi-species NOE1/ OLFM1/ AMY protein


    Target information

    Target IDGM-SE0385
    Target NameOLFM1
    Gene ID10439,56177,93667,712348,480685,101081422,507002,100066407
    Gene Symbol and SynonymsAMY,D2Sut1e,NOE1,NOELIN1,OlfA,OLFM1,Pancortin,Pancortin3
    Uniprot AccessionQ99784,Q62609
    Uniprot Entry NameNOE1_HUMAN,NOE1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseLung Cancer
    Gene EnsemblENSG00000130558
    Target ClassificationN/A

    The target: OLFM1, gene name: OLFM1, also named as AMY, NOE1, NOELIN1, OlfA. This gene product shares extensive sequence similarity with the rat neuronal olfactomedin-related ER localized protein. While the exact function of the encoded protein is not known, its abundant expression in brain suggests that it may have an essential role in nerve tissue. Several alternatively spliced transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.